Effect of Preoperative Creatinine Levels on Mortality after Coronary Artery Bypass Grafting Surgery: an Observational

Insights

Admission creatinine levels significantly impact mortality risk in on-pump coronary artery bypass grafting (ONCABG) patients. Higher creatinine levels, especially with other risk factors, worsen prognosis, while lower levels offer protection.

Area of Science:

  • Cardiology
  • Nephrology
  • Surgical Outcomes

Background:

  • Renal function is a critical predictor of mortality in patients undergoing on-pump coronary artery bypass grafting (ONCABG).
  • Limited understanding exists on how admission creatinine (AC) levels specifically influence cardiovascular risk factors in this population.

Purpose of the Study:

  • To investigate the impact of varying admission creatinine levels on mortality rates among ONCABG patients.
  • To analyze the association between different AC strata and specific cardiovascular risk factors.

Main Methods:

  • A retrospective analysis of 1,599 patients who underwent ONCABG between 1999 and 2006.
  • Patients were categorized into four quartiles based on admission creatinine levels (QI: 0.2–0.99 mg/dL, QII: 1.0–1.19 mg/dL, QIII: 1.2–1.39 mg/dL, QIV: ≥1.4 mg/dL).
  • Seven cardiovascular risk factors were assessed within each AC quartile.

Main Results:

  • Mortality rates were significantly higher in the highest creatinine quartile (QIV) compared to lower quartiles (QI, QII).
  • Factors like advanced age (≥65 years), prolonged cardiopulmonary bypass time (≥115 minutes), and preoperative hospital stay (≥5 days) were linked to increased mortality in higher AC groups.
  • A creatinine variation of ≥0.4 mg/dL, use of intra-aortic balloon pump, dialysis, and Type I neurological dysfunction were associated with increased mortality, with variations depending on the AC quartile.

Conclusions:

  • Admission creatinine levels are a crucial determinant of mortality following ONCABG.
  • The combination of elevated AC levels and other cardiovascular risk factors portends a poorer prognosis.
  • Lower AC levels demonstrate a protective effect, even in high-risk patient subgroups such as the elderly or those with extended CPB times.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
966
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
414
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
239
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
623
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359